Previewing the 2024 Fall SDPA Conference: What to Expect
The conference aimed at providing physician assistants with the latest in dermatology advancements begins today in Las Vegas, Nevada.
Analysis Finds Higher Likelihood of Improved QoL in Atopic Dermatitis for Dupilumab vs Lebrikizumab
Poster compared quality of life improvement for dupilumab vs lebrikizumab in atopic dermatitis.
Dermatology Times' Parent Company, MJH Life Sciences, Acquires Revolutionizing Atopic Dermatitis (RAD) Conference
RAD will join MJH's multichannel model, enhancing its educational impact in atopic dermatitis, alopecia areata, vitiligo, and eczema.
Jenny Murase, MD: Providing Dermatologic Support in Postpartum Care
Murase discussed safe dermatologic treatments during lactation, especially for chronic conditions needing biologics.
"Baby Bumps": Jenny Murase, MD, on Dermatoses During Pregnancy
Murase identifies 4 main pregnancy dermatoses—atopic eruption, polymorphic eruption, extrahepatic cholestasis, and pemphigoid gestationis—as "baby bumps."
Conference Recap: Elevate-Derm West 2024
Catch up on coverage from the 2024 Elevate-Derm West Conference in Scottsdale, Arizona.
Day 4 Recap: Elevate-Derm West 2024
Catch up on coverage from the fourth and final day of the 2024 Elevate-Derm West Conference in Scottsdale, Arizona.
Desert Gems in Dermatology: Insights from Elevate-Derm West 2024
Discover top innovations, insights, and clinical pearls from Elevate-Derm in Scottsdale, where top insights for advanced practice providers took center stage.
Jenny Murase, MD: Emerging Therapies Bring Hope to Patients with Persistent Itch
At Elevate-Derm West, Murase shared promising results in treating severe itch with emerging therapies, offering hope for patients with few options.
Pediatric Dermatology Essentials: Lisa Swanson, MD, on Treating Young Patients with Confidence
Swanson shared practical tips from her Elevate-Derm West sessions, empowering clinicians with new strategies for pediatric skin care.
Navigating Skin Disease Treatment During Pregnancy
Murase noted small molecule treatments, like JAK inhibitors, remain unsafe for pregnant women.
Ashfaq Marghoob, MD: Identifying Dermoscopic Patterns in Facial, Palmoplantar, Nail, and Mucosal Lesions
Marghoob shares key dermoscopic features to help clinicians identify benign vs malignant lesions on various locations of the body.
Day 3 Recap: Elevate-Derm West 2024
Catch up on coverage from the third day of the 2024 Elevate-Derm West Conference in Scottsdale, Arizona.
CAB Gel Shows Promising Results for Hispanic Patients with Acne
The study demonstrated significant reductions in inflammatory and non-inflammatory lesions for Hispanic patients using CAB gel.
Latest Laser and Skincare Innovations for Hyperpigmentation with Suneel Chilukuri, MD, FAAD, FACMS
Chilukuri shared that 2 new sunscreen ingredients, physalis angulata and pycnogenol, can prevent heat-induced pigmentation, offering new options for patients.
DELTA 2 Trial Shows Delgocitinib Cream Safe with Minimal Systemic Absorption for Chronic Hand Eczema
Delgocitinib cream offers a safe, low-systemic-exposure option for chronic hand eczema, according to a poster from the Elevate-Derm conference.
Updates on the Latest Cosmetic Treatments in Medical Care
Affordable at-home treatments, including microneedling and benzoyl peroxide, were top pearls at Chilukuri's Elevate-Derm session.
Real-World Data on Tralokinumab Demonstrates Effective Relief for Patients With Atopic Dermatitis Affecting the Genitals
The TRACE study showed tralokinumab reduced genital AD severity and improved quality of life within 3 months of treatment.
Day 2 Recap: Elevate-Derm West 2024
Catch up on coverage from the second day of the 2024 Elevate-Derm West Conference in Scottsdale, Arizona.
Exploring Diet and New Treatments for Hidradenitis Suppurativa
From diet recommendations to biologic advancements, Jennifer Hsiao, MD, covered essential updates for treating patients with HS.